Save
OUTCOMES IN TRANSFUSED CARDIAC SURGERY PATIENTS
ESRA Academy. J. Papadimos T. Sep 8, 2016; 138443
Topic: Thoracic Surgery - Analgesia after Thoracotomy - Cardiac Surgery- Vascular Surgery
Prof. Thomas J. Papadimos
Prof. Thomas J. Papadimos

Access to Premium content is currently a membership benefit.


Click here to join ESRA or renew your membership.

Abstract
Discussion Forum (0)
Rate & Comment (0)
Background and Aims:

New data indicate that patients who receive RBC transfusions are more likely to have postoperative complications and increased risk of mortality. Studies suggest an association between transfusion in critically ill patients and poorer outcomes. Few studies have looked at the effects of transfusion, specifically in cardiac surgery patients.

Objective

The authors hypothesized that in a cohort of cardiac surgery transfused patients would have increased 30-day and 1-year mortality compared to non-transfused patients.


Methods:

A retrospective quality analysis of 1,409 patients undergoing CABG surgery at OSUMC between 2008 and 2013 was performed. Data collection included: Patient demographics, baseline labs, transfusion timing, units transfused, postoperative labs, adverse events, length of stay (LOS), and 30-day and 1-year postoperative mortality. Continuous variables are expressed as mean ± (SD) and categorical variables, percentages.

Results:

Of the 1,409 patients analyzed, 717 patients received blood and 682 did not. The average units of RBCs given intraoperatively was 2.01  1.5 and postoperatively, 2.90  2.86. Transfused patients stayed 3.39 days longer than non-transfused patients. At 30 days post-op, 2.81% of transfused patients had died compared to 0.59% of non-transfused patients; by 1 year post-op, 13.87% of transfused patients had died compared to 3.59% of non-transfused patients.





Conclusions:

Transfused CABG patients showed an increased LOS and 30-day and 1-year mortality. These outcomes may not be due to surgical complications, but rather to transfusion itself. Overall, RBC transfusion did not appear to improve outcomes for patients in this study

Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings